Tumour-targeting bacteria engineered to fight cancer

S Zhou, C Gravekamp, D Bermudes, K Liu - Nature Reviews Cancer, 2018 - nature.com
Recent advances in targeted therapy and immunotherapy have once again raised the hope
that a cure might be within reach for many cancer types. Yet, most late-stage cancers are …

Cell penetrating peptides as molecular carriers for anti-cancer agents

A Borrelli, AL Tornesello, ML Tornesello… - Molecules, 2018 - mdpi.com
Cell membranes with their selective permeability play important functions in the tight control
of molecular exchanges between the cytosol and the extracellular environment as the …

Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin

JH Zheng, VH Nguyen, SN Jiang, SH Park… - Science translational …, 2017 - science.org
We report a method of cancer immunotherapy using an attenuated Salmonella typhimurium
strain engineered to secrete Vibrio vulnificus flagellin B (FlaB) in tumor tissues. Engineered …

[HTML][HTML] Cell-penetrating peptides in protein mimicry and cancer therapeutics

M Zorko, S Jones, Ü Langel - Advanced drug delivery reviews, 2022 - Elsevier
Extensive research has been undertaken in the pursuit of anticancer therapeutics. Many
anticancer drugs require specificity of delivery to cancer cells, whilst sparing healthy tissue …

Bacterially mediated drug delivery and therapeutics: Strategies and advancements

L Wu, F Bao, L Li, X Yin, Z Hua - Advanced drug delivery reviews, 2022 - Elsevier
It was already clinically apparent 150 years ago that bacterial therapy could alleviate
diseases. Recently, a burgeoning number of researchers have been using bacterial …

Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

Y Liu, L Niu, N Li, Y Wang, M Liu, X Su, X Bao… - Advanced …, 2023 - Wiley Online Library
Targeted therapy and immunotherapy have brought hopes for precision cancer treatment.
However, complex physiological barriers and tumor immunosuppression result in poor …

[HTML][HTML] Salmonella typhimurium suppresses tumor growth via the pro-inflammatory cytokine interleukin-1β

JE Kim, TX Phan, VH Nguyen, HV Dinh-Vu… - Theranostics, 2015 - ncbi.nlm.nih.gov
Although strains of attenuated Salmonella typhimurium and wild-type Escherichia coli show
similar tumor-targeting capacities, only S. typhimurium significantly suppresses tumor growth …

[HTML][HTML] Bacteria and bacterial derivatives as delivery carriers for immunotherapy

SR Kang, DH Nguyen, SW Yoo, JJ Min - Advanced Drug Delivery Reviews, 2022 - Elsevier
There is growing interest in the role of microorganisms in human health and disease, with
evidence showing that new types of biotherapy using engineered bacterial therapeutics …

Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy

K Liang, Q Liu, P Li, H Luo, H Wang, Q Kong - Cancer letters, 2019 - Elsevier
Bacteria have been investigated as anti-tumor therapeutic agents for more than a century,
since Coley first observed successful curing of a patient with inoperable cancer by injection …

An update on cell-penetrating peptides with intracellular organelle targeting

CP Cerrato, Ü Langel - Expert Opinion on Drug Delivery, 2022 - Taylor & Francis
Introduction Cell-penetrating peptide (CPP) technologies represent an important strategy to
address drug delivery to specific intracellular compartments by covalent conjugation to …